(1S,4S)-2λ⁶-thia-5-azabicyclo[2.2.1]heptane 2,2-dioxide;hydrochloride
|
T629403-1g
|
≥97% |
1481613-21-1 |
1g
|
¥ 4283.9
|
期货,请咨询 |
阿拉丁 |
(1S,4S)-2λ⁶-thia-5-azabicyclo[2.2.1]heptane 2,2-dioxide;hydrochloride
|
T629403-100mg
|
≥97% |
1481613-21-1 |
100mg
|
¥ 1073.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl N-{6-azaspiro[2.5]octan-1-yl}carbamate
|
T629394-5g
|
≥97% |
147632-34-6 |
5g
|
¥ 10164.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl N-{6-azaspiro[2.5]octan-1-yl}carbamate
|
T629394-500mg
|
≥97% |
147632-34-6 |
500mg
|
¥ 1522.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl N-{6-azaspiro[2.5]octan-1-yl}carbamate
|
T629394-250mg
|
≥97% |
147632-34-6 |
250mg
|
¥ 1014.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl N-{6-azaspiro[2.5]octan-1-yl}carbamate
|
T629394-1g
|
≥97% |
147632-34-6 |
1g
|
¥ 2539.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl N-{6-azaspiro[2.5]octan-1-yl}carbamate
|
T629394-10g
|
≥97% |
147632-34-6 |
10g
|
¥ 20328.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl N-{6-azaspiro[2.5]octan-1-yl}carbamate
|
T629394-100mg
|
≥97% |
147632-34-6 |
100mg
|
¥ 506.9
|
期货,请咨询 |
阿拉丁 |
2,4,8-trichloropyrido[3,4-d]pyrimidine
|
T629384-500mg
|
≥97% |
1470249-17-2 |
500mg
|
¥ 1209.9
|
期货,请咨询 |
阿拉丁 |
2,4,8-trichloropyrido[3,4-d]pyrimidine
|
T629384-250mg
|
≥97% |
1470249-17-2 |
250mg
|
¥ 607.9
|
期货,请咨询 |
阿拉丁 |
2,4,8-trichloropyrido[3,4-d]pyrimidine
|
T629384-100mg
|
≥97% |
1470249-17-2 |
100mg
|
¥ 366.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl N-[trans-2-fluorocyclopropyl]carbamate
|
T629376-5g
|
≥97% |
146726-40-1 |
5g
|
¥ 9208.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl N-[trans-2-fluorocyclopropyl]carbamate
|
T629376-1g
|
≥97% |
146726-40-1 |
1g
|
¥ 2875.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl N-[trans-2-fluorocyclopropyl]carbamate
|
T629376-10g
|
≥97% |
146726-40-1 |
10g
|
¥ 18416.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1,4-benzoxazine-4-carboxylate
|
T629374-5g
|
≥97% |
1467057-57-3 |
5g
|
¥ 10210.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1,4-benzoxazine-4-carboxylate
|
T629374-500mg
|
≥97% |
1467057-57-3 |
500mg
|
¥ 3298.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1,4-benzoxazine-4-carboxylate
|
T629374-250mg
|
≥97% |
1467057-57-3 |
250mg
|
¥ 1884.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1,4-benzoxazine-4-carboxylate
|
T629374-1g
|
≥97% |
1467057-57-3 |
1g
|
¥ 4899.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1,4-benzoxazine-4-carboxylate
|
T629374-100mg
|
≥97% |
1467057-57-3 |
100mg
|
¥ 1107.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 3-(1-cyano-1-methylethyl)azetidine-1-carboxylate
|
T629371-5g
|
≥97% |
1466514-81-7 |
5g
|
¥ 19206.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 3-(1-cyano-1-methylethyl)azetidine-1-carboxylate
|
T629371-500mg
|
≥97% |
1466514-81-7 |
500mg
|
¥ 2558.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 3-(1-cyano-1-methylethyl)azetidine-1-carboxylate
|
T629371-250mg
|
≥97% |
1466514-81-7 |
250mg
|
¥ 1535.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 3-(1-cyano-1-methylethyl)azetidine-1-carboxylate
|
T629371-1g
|
≥97% |
1466514-81-7 |
1g
|
¥ 3841.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 3-(1-cyano-1-methylethyl)azetidine-1-carboxylate
|
T629371-100mg
|
≥97% |
1466514-81-7 |
100mg
|
¥ 961.9
|
期货,请咨询 |
阿拉丁 |